M&G Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
M&G Investment Management's PFE Position: Q4 2023 in Review
M&G Investment Management increased its Pfizer (PFE) stake by 33% in Q4 2023, buying an estimated $7.62M and bringing the position to 1,027,780 shares worth $29.8M. The position accounts for 0.11% of the portfolio, ranked #103.
M&G Investment Management first reported a position in PFE in Q4 2019 and has held it in 17 quarters since. The position peaked at $54.3M in Q4 2019. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- M&G Investment Management held 1,027,780 shares of Pfizer worth $29.8M as of Q4 2023.
- M&G Investment Management bought 252,116 Pfizer shares in Q4 2023, an estimated $7.62M.
- Pfizer made up 0.11% of M&G Investment Management's portfolio in Q4 2023, its #103 holding.
- M&G Investment Management first reported a position in Pfizer in Q4 2019 and has held it in 17 quarters since.
- M&G Investment Management's Pfizer position peaked at $54.3M in Q4 2019.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.